Chronic Infection with Hepatitis C Virus Subtype 1 g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir-Reference-Cited by-同舟云学术

Chronic Infection with Hepatitis C Virus Subtype 1 g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir

Published:2022 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hatanaka Takeshi¹,Kakizaki Satoru²,Kaburagi Takuya¹,Saito Naoto¹,Nakano Sachi¹,Hazama Yoichi¹,Yoshida Sachiko¹,Hachisu Yoko¹,Tanaka Yoshiki¹,Yoshinaga Teruo¹,Kashiwabara Kenji³,Naganuma Atsushi⁴,Yamazaki Yuichi⁵,Uraoka Toshio⁵,Nagashima Shigeo⁶,Takahashi Masaharu⁶,Nishizawa Tsutomu⁶,Murata Kazumoto⁶,Okamoto Hiroaki⁶

Affiliation:

1. Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Japan

2. Department of Clinical Research, National Hospital Organization Takasaki General Medical Center, Japan

3. Department of Pathology, Gunma Saiseikai Maebashi Hospital, Japan

4. Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Japan

5. Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan

6. Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_8673-21/_pdf

Reference26 articles.

1. 1. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 388: 1081-1088, 2016.

2. 2. Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2: 161-176, 2017.

3. 3. Pisano MB, Giadans CG, Flichman DM, Ré VE, Preciado MV, Valva P. Viral hepatitis update: Progress and perspectives. World J Gastroenterol 27: 4018-4044, 2021.

4. 4. Omata M, Kanda T, Yokosuka O, et al. Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries. Hepatol Int 9: 486-507, 2015.

5. 5. Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 370: 1889-1898, 2014.